Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Interstitial Fluid in the Development of Cardiovascular Disease

Lead Sponsor:

Karolinska University Hospital

Collaborating Sponsors:

Karolinska Institutet

Conditions:

Type2 Diabetes

Atherosclerosis

Eligibility:

All Genders

18+ years

Brief Summary

At a given level of serum cholesterol, patients with T2D have an increased risk of developing atherosclerosis compared with nondiabetic subjects. In a previous study we showed that the interstitial f...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Over 18 years.
  • For the T2D study group: Diagnosed with type 2 diabetes.
  • Exclusion criteria:
  • For subjects with type 2 diabetes:
  • Systemic inflammatory disease that requires active treatment
  • Thyroid disease that requires active treatment
  • Skin disease that requires active treatment and causes significant changes in the area of the skin that is to be investigated
  • Treatment with oral glucocorticoids
  • Levels of SR, TSH, T4 or Hemoglobin in the blood pronouncedly outside the reference range
  • Pregnancy
  • For healthy controls:
  • Registered disease in the health declaration that requires continuous systemic treatment. Exception to the above: well controlled hypertension in which case the subject should not have treatment with more than one antihypertensive drug, the drug must not be an alpha-blocker or beta-blocker or thiazide diuretic
  • Skin disease that requires active treatment and causes significant changes in the area of the skin that is to be investigated
  • Blood pressure pronouncedly above 140/90
  • Blood test results pronouncedly outside the reference range
  • Pregnancy

Exclusion

    Key Trial Info

    Start Date :

    January 10 2018

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 3 2021

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT03386097

    Start Date

    January 10 2018

    End Date

    September 3 2021

    Last Update

    September 9 2021

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Ekerö Vårdcentral

    Ekerö, Ekerö Kommun, Sweden, 17831

    2

    Patient research centre, Clinic of endocrinology, Karolinska University Hospital

    Huddinge, Stockholm County, Sweden, 14186

    3

    Stiftelsen Stockholms Sjukhems Husläkarmottagning

    Stockholm, Sweden, 11219

    4

    GIH (gymnastik och idrottshögskolan)

    Stockholm, Sweden, 11433